Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent oral levetiracetam to prevent recurrent febrile seizures monitored by iThermonitor
ChiCTR-IPR-15007241Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levetiracetam in febrile seizure (FS) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoints: Seizure frequency associated with febrile events and Febrile seizure recurrence rate. Planned start Oct 2015; status: not yet recruiting.
02
Drugs
levetiracetam
03
Conditions
febrile seizure (FS)
Beyond the preview
Go deeper on ChiCTR-IPR-15007241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007241.